TOMI Environmental Solutions’ SteraMist is a non-thermal atmospheric plasma disinfection system that uses ionized hydrogen peroxide (iHP) to inactivate pathogens on surfaces and in the air. Originally developed under a DARPA-related U.S. defense initiative, the technology is now being adopted across high-risk environments such as cruise ships, hospitals, hotels, airports, and commercial facilities to combat outbreaks of Norovirus, Hantavirus, and other infectious diseases.
Overview
SteraMist’s core technology, Binary Ionization Technology (BIT), generates a mist of ionized hydrogen peroxide that acts like a non-caustic gas, penetrating hard-to-reach surfaces and enclosed spaces. Unlike traditional manual cleaning methods, it is designed for rapid deployment in large-scale environments, minimizing downtime while providing hospital-grade disinfection. The system has already been validated in healthcare, pharmaceutical manufacturing, aerospace, and biohazard remediation settings.
Key Applications
The technology is positioned for use in:
- Cruise ships – Routine disinfection of cabins, dining areas, and common spaces to prevent outbreaks and restore passenger confidence.
- Hospitals and healthcare facilities – Infection control in patient rooms, operating theaters, and high-touch surfaces.
- Hotels and resorts – Proactive decontamination to address guest concerns over sanitation standards.
- Airports and transportation hubs – Disinfection of terminals, baggage areas, and public transit systems.
- Schools and universities – Mitigating outbreaks in high-density environments.
- Sports arenas and entertainment venues – Large-scale event sanitation.
- Government and military facilities – Biosecurity and environmental remediation.
Market Drivers
Recurring outbreaks of Norovirus, Hantavirus, and other pathogens have heightened demand for scalable disinfection solutions. Cruise ship operators, in particular, face mounting pressure to adopt advanced decontamination protocols after multiple high-profile outbreaks sickened hundreds of passengers and crew. Industry analysts suggest that companies able to market hospital-grade disinfection as a competitive differentiator—such as SteraMist—could gain a trust advantage with travelers.
The shift from reactive cleaning to continuous, proactive decontamination is also being driven by long-term changes in public health expectations post-COVID-19. What was once considered emergency spending is now becoming embedded operational infrastructure, with infection prevention viewed as a durable growth sector rather than a temporary trend.
Tradeoffs
While SteraMist offers advantages over traditional cleaning methods—such as faster deployment and broader surface coverage—its adoption depends on factors like cost, training requirements, and integration with existing sanitation protocols. The technology’s reliance on hydrogen peroxide also necessitates proper ventilation and safety measures during application.
Bottom Line
SteraMist’s ability to deliver rapid, large-scale disinfection positions it as a potential category leader in infection prevention. As outbreaks continue to drive demand for hospital-grade decontamination, the technology could see wider adoption across industries where public health and reputational risks intersect with operational needs.